Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Deferred Taxes: 2020-2021

Historic Deferred Taxes for Neurocrine Biosciences (NBIX) over the last 1 years, with Dec 2021 value amounting to -$4.7 million.

  • Neurocrine Biosciences' Deferred Taxes rose 98.49% to -$4.7 million in Q4 2021 from the same period last year, while for Dec 2021 it was $4.3 million, marking a year-over-year change of. This contributed to the annual value of -$123.1 million for FY2024, which is 117.11% down from last year.
  • Per Neurocrine Biosciences' latest filing, its Deferred Taxes stood at -$4.7 million for Q4 2021, which was down 182.46% from $5.7 million recorded in Q3 2021.
  • In the past 5 years, Neurocrine Biosciences' Deferred Taxes ranged from a high of $9.5 million in Q2 2021 and a low of -$310.7 million during Q4 2020.
  • In the last 2 years, Neurocrine Biosciences' Deferred Taxes had a median value of -$4.7 million in 2021 and averaged -$61.3 million.
  • Data for Neurocrine Biosciences' Deferred Taxes shows a peak YoY spiked of 98.49% (in 2021) over the last 5 years.
  • Quarterly analysis of 2 years shows Neurocrine Biosciences' Deferred Taxes stood at -$310.7 million in 2020, then soared by 98.49% to -$4.7 million in 2021.
  • Its last three reported values are -$4.7 million in Q4 2021, $5.7 million for Q3 2021, and $9.5 million during Q2 2021.